Other products from "SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 00842768039416 10873440 B4265-37 For coagulation tests and as a rinsing solution for the sample needles of the Sy For coagulation tests and as a rinsing solution for the sample needles of the Sysmex® CA Systems KQJ SYSTEM, FIBRINOGEN DETERMINATION Dade® CA System Buffer
2 00842768028441 10385332 LKPM For use in daily maintenance of the IMMULITE® and IMMULITE® 1000 systems JJQ COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE 1 IMMULITE® Probe Cleaning Kit
3 00842768028427 10385231 L2PWSM For use in the routine operation of the IMMULITE® 2000 and IMMULITE® 2500 Analyzers JJQ COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE IMMULITE 2000/XPi Probe Wash Module
4 00842768017872 10446691 OWZG23 Quantitative determination of fibrinogen in plasma KQJ SYSTEM, FIBRINOGEN DETERMINATION Multifibren® U
5 00842768017865 10446689 OWZG19 Quantitative determination of fibrinogen in plasma KQJ SYSTEM, FIBRINOGEN DETERMINATION Multifibren® U
6 00842768017087 10873532 OPOD05 For quality control of the INNOVANCE® Heparin assay GGN Plasma, coagulation control INNOVANCE Heparin UF Control 2
7 00842768016134 10446085 OQIO19 N/T Protein Control SL/M is a medium level, multi-analyte control for use as acc N/T Protein Control SL/M is a medium level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems JJY Multi-analyte controls, all kinds (assayed) N/T Protein Control SL/M
8 00842768016110 10446089 OQIP19 N/T Protein Control SL/H is a high level, multi-analyte control for use as accur N/T Protein Control SL/H is a high level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems JJY Multi-analyte controls, all kinds (assayed) N/T Protein Control SL/H
9 00842768013065 10446632 OWMG15 Quantitative determination of thrombin/antithrombin III complex (TAT) in human plasma JBQ ANTITHROMBIN III QUANTITATION 2 Enzygnost® TAT micro
10 00842768012945 10446620 OWLD11 Determination of heparin activity in plasma and for the monitoring of heparin therapy KFF ASSAY, HEPARIN 2 Berichrom® Heparin
11 00842768011030 10446415 OTXY13 For the determination of the activity of coagulation factor X in human plasma by For the determination of the activity of coagulation factor X in human plasma by coagulometric methods GJT PLASMA, COAGULATION FACTOR DEFICIENT Coagulation Factor X Deficient Plasma
12 00842768009976 10446316 OSDF13 For the determination of the activity of coagulation factor XI in human plasma b For the determination of the activity of coagulation factor XI in human plasma by coagulometric methods GJT PLASMA, COAGULATION FACTOR DEFICIENT Coagulation Factor XI Deficient Plasma
13 00842768009761 10446295 OSAR19 Quantitative determination of IgA in human serum and plasma on BN Systems CFN METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) 2 N Antisera to Human IgA
14 00842768009747 10446293 OSAR11 Quantitative determination of IgA in human serum and plasma on BN Systems CFN METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) 2 N Antisera to Human IgA
15 00842768008153 10446136 OQUB21 Cleaning solution BN II, BN ProSpec® Systems and BCS® Systems JZW NEPHELOMETER Cleaner SCS
16 00842768008054 10446127 OQTC11 Quantitative determination of soluble transferrin receptor (sTfR) in human serum Quantitative determination of soluble transferrin receptor (sTfR) in human serum and heparinized plasma on BN Systems DDG TRANSFERRIN, ANTIGEN, ANTISERUM, CONTROL N Latex sTfR
17 00842768007477 10461887 OQGP15 LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants GIR REAGENT, RUSSEL VIPER VENOM LA 1 Screening Reagent
18 00842768007279 10446043 OQDC13 Assayed control for RF ASL and CRP assays on Siemens Systems JJY Multi-analyte controls, all kinds (assayed) N/T Rheumatology Control SL/2
19 00842768006876 10445990 OPCD03 For use as a low level assayed control for the quantitative measurement of low m For use as a low level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin GIZ PLASMA, CONTROL, NORMAL Berichrom® Heparin LMW Control 1
20 00842768006845 10445987 OPCA03 For calibration of the Berichrom Heparin assay for measurement of low molecular For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin JPA SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES Berichrom® Heparin LMW Calibrator
21 00842768006838 10445986 OPBZ03 For use as a high level assayed control for the quantitative measurement of unfr For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin GGC CONTROL, PLASMA, ABNORMAL Berichrom® Heparin UF Control 2
22 00842768006715 10445973 OPAX03 Quantitative determination of homocysteine in human serum and plasma on BN II an Quantitative determination of homocysteine in human serum and plasma on BN II and BN ProSpec® Systems LPS URINARY HOMOCYSTINE (NONQUANTITATIVE) TEST SYSTEM 2 N Latex HCY
23 00842768006388 10445924 KC735 CYSC CON L is an assayed intralaboratory quality control for assessment of preci CYSC CON L is an assayed intralaboratory quality control for assessment of precision and analytical bias in the determination of the CYSC method on the Dimension Vista® System JJY Multi-analyte controls, all kinds (assayed) DImension Vista® Cystatin C Control L (low)
24 00842768006340 10445920 KC716 PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality con PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality control for the assessment of precision and analytical bias on the Dimension Vista® System JJY Multi-analyte controls, all kinds (assayed) DImension Vista® Protein 1 Control M (medium)
25 00842768004056 10445731 B4244-10 For use as control in citrated coagulation systems GGC CONTROL, PLASMA, ABNORMAL Dade® Ci-Trol® Coagulation Control Level 1
26 00842768006173 10445902 K7054 For the quantitative measurement of immunoglobulin E in human serum and plasma ( For the quantitative measurement of immunoglobulin E in human serum and plasma (heparin or EDTA) on the Dimension Vista® System DGC IGE, ANTIGEN, ANTISERUM, CONTROL DImension Vista® Immunoglobulin E Flex® reagent cartridge
27 00842768006135 10445898 K7046 For the quantitative measurement of C-reactive protein in human serum and plasma For the quantitative measurement of C-reactive protein in human serum and plasma on the Dimension Vista® System NQD CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL Dimension Vista hsCRP Flex reagent cartridge
28 00842768006128 10445897 K7044 For the quantitative measurement of total homocysteine in human serum and plasma For the quantitative measurement of total homocysteine in human serum and plasma on the Dimension Vista® System LPS URINARY HOMOCYSTINE (NONQUANTITATIVE) TEST SYSTEM DImension Vista® Homocysteine Flex® reagent cartridge
29 00842768003967 10445722 B4233-60 The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantita The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (XL-FDP) in human plasma DAP FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL 2 Dade® DIMERTEST® Latex Assay
30 00842768003929 10445718 B4233-15SY Quantitative determination of fibrinogen in human plasma GFK FIBRINOGEN DETERMINATION STANDARDS AND CONTROLS 2 Dade® Fibrinogen Determination Reagents
31 00842768003905 10445716 B4224-60 Control in heparin assay procedures KFF ASSAY, HEPARIN Dade® Ci-Trol® Heparin Control, High
32 00842768003899 10445715 B4224-50 Control in heparin assay procedures KFF ASSAY, HEPARIN Dade® Ci-Trol® Heparin Control, Low
33 00630414992617 10459382 B4132-1A For differential staining in hematology that gives results similar to a Wright-G For differential staining in hematology that gives results similar to a Wright-Giemsa stain KQC STAINS, HEMATOLOGY 1 Diff-Quik™ Stain Set
34 00630414285054 10873691 OWTI15 Quantitative determination of ADNase B in human serum on BN Systems GTR ANTIDEOXYRIBONUCLEASE, STREPTOCOCCUS SPP. 1 N Latex ADNase B (USA)
35 00630414284996 10873685 OQDC17 Assayed control for RF, ASL and CRP assays on BN Systems JJY Multi-analyte controls, all kinds (assayed) 1 N/T Rheumatology Control SL/2
36 00630414237503 10873663 OPJF05 Assayed accuracy and precision controls in the determination of free light chain Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems. JJY Multi-analyte controls, all kinds (assayed) N FLC CONTROL SL2
37 00630414237480 10873661 OPJE05 Assayed accuracy and precision controls in the determination of free light chain Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems. JJY Multi-analyte controls, all kinds (assayed) N FLC CONTROL SL1
38 00630414023526 10873571 B4233-17SY Quantitative determination of fibrinogen in human plasma GFK FIBRINOGEN DETERMINATION STANDARDS AND CONTROLS 2 Dade® Fibrinogen Determination Reagents
39 00630414002736 10465217 OVLI012 The BN ProSpec® is a system for the quantitative determination of proteins in se The BN ProSpec® is a system for the quantitative determination of proteins in serum, plasma, urine and CSF JZW NEPHELOMETER 1 BN ProSpec® System
40 00842768028410 10385393 LPWS2 For use in the routine operation of the IMMULITE® and IMMULITE® 1000 Analyzers JJQ COLORIMETER, PHOTOMETER, SPECTROPHOTOMETER FOR CLINICAL USE IMMULITE® Probe Wash Module
41 00842768018534 10445997 OPCS05 Quantitative determination of carbohydrate-deficient transferrin (CDT) in human Quantitative determination of carbohydrate-deficient transferrin (CDT) in human serum on BN II and BN ProSpec® Systems NAO Test,carbohydrate deficient transferrin 1 N Latex CDT Kit
42 00842768014222 10446232 ORHO37 Supplementary Reagent for coagulation tests JPA SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES Calcium Chloride Solution
43 00842768013478 10446673 OWWR17 Determination of the functional activity of antithrombin III (AT III) in human plasma JPE ANTITHROMBIN III, TWO STAGE CLOTTING TIME ASSAY 2 Berichrom® Antithrombin III (A)
44 00842768013461 10446672 OWWR15 Determination of the functional activity of antithrombin III (AT III) in human plasma JPE ANTITHROMBIN III, TWO STAGE CLOTTING TIME ASSAY 2 Berichrom® Antithrombin III (A)
45 00842768012778 10446604 OWHU21 Qualitative detection or semi-quantitative determination of C-reactive protein ( Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum DCN SYSTEM, TEST, C-REACTIVE PROTEIN 2 RapiTex® CRP
46 00842768012686 10446595 OWHG13 Quantitative determination of Ig light chains, type kappa in human serum on BN Systems DFH KAPPA, ANTIGEN, ANTISERUM, CONTROL 2 N Antiserum to Human-Ig/L-chain, K-type
47 00842768012297 10446534 OVLC21 The N Evaporation Cap 2.5ml is part of the BN ProSpec system. JZW NEPHELOMETER N Evaporation Caps for Control Vials (2.5 mL)
48 00842768012174 10446521 OVIC11 The N Predilution Well is used for settings of dilutions of standards, controls and sera. DEW IGG, ANTIGEN, ANTISERUM, CONTROL N Predilution Wells
49 00842768011443 10446458 OUMU15 Supplementary reagent for multiple protein assays on Siemens systems CFN METHOD, NEPHELOMETRIC, IMMUNOGLOBULINS (G, A, M) 2 N Supplementary Reagent/Precipitation
50 00842768011085 10446420 OUAX41 Qualitative detection or semi-quantitative determination of C-reactive protein ( Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum DCN SYSTEM, TEST, C-REACTIVE PROTEIN 2 RapiTex® CRP
Other products with the same Product Code "GGP"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 05391521420916 T6003 TriniLIZE™ PAI-1 Antigen TCOAG IRELAND LIMITED
2 05391521420909 T6004 TriniLIZE™ PAI-1 Activity TCOAG IRELAND LIMITED
3 05391521420565 T2608 TriniCHROM™ Factor VIII:C TCOAG IRELAND LIMITED
4 05391521420466 T1602 TriniCLOT™ Protein S TCOAG IRELAND LIMITED
5 05391521420091 50710 Lyophilized Platelets TCOAG IRELAND LIMITED
6 05391521420077 50750 Ristocetin Cofactor Assay TCOAG IRELAND LIMITED
7 05051700005807 GT118.3 Human Protein C ‘NL’ NANORIDTM Radial Immunodiffusion Kit THE BINDING SITE GROUP LIMITED
8 G0561067301 106730 106730 vW Select Kit (Ristocetin Cofactor) BIO/DATA CORPORATION
9 G0561064261 106426 106426 vW Normal Control Plasma BIO/DATA CORPORATION
10 G0561030251 103025 103025 vW Factor Assay (Ristocetin Cofactor) BIO/DATA CORPORATION
11 G0561015951 3 X 4.0 mL 101595 Lyophilized Platelets BIO/DATA CORPORATION
12 G0561012701 101270 101270 vW Abnormal Control Plasma BIO/DATA CORPORATION
13 G0561012691 101269 101269 vW Normal Reference Plasma BIO/DATA CORPORATION
14 G0561012580 10mL 101258 Lyophilized Platelets BIO/DATA CORPORATION
15 03663537008238 221205 221205 BIOPHEN Protein C 5 HYPHEN BIOMED
16 03663537008221 221202 221202 BIOPHEN Protein C 2.5 HYPHEN BIOMED
17 03607450009484 00948 Asserachrom® tPA DIAGNOSTICA STAGO
18 03607450009460 00946 Asserachrom® Free Protein S DIAGNOSTICA STAGO
19 03607450009453 00945 Asserachrom® Total Protein S DIAGNOSTICA STAGO
20 03607450009439 00943 Asserachrom® IX:Ag DIAGNOSTICA STAGO
21 03607450009422 00942 Asserachrom® VWF:Ag DIAGNOSTICA STAGO
22 03607450007473 00747 STA® - Staclot® Protein C 1 DIAGNOSTICA STAGO
23 03607450007466 00746 STA® - Staclot® Protein S DIAGNOSTICA STAGO
24 03607450007374 00737 STA® - Staclot® Protein C 3 DIAGNOSTICA STAGO
25 03607450006711 00671 STA® - Stachrom® Protein C DIAGNOSTICA STAGO
26 03607450006599 00659 STA® - Stachrom® Antiplasmin DIAGNOSTICA STAGO
27 03607450005707 00570 Liatest® Protein S DIAGNOSTICA STAGO
28 03607450005165 00516 STA® - Liatest® Free Protein S 6 DIAGNOSTICA STAGO
29 00859394006095 90-480 90-480 Protein S Kit 80-160 DET ThromboTek PSe R 2 DIAGNOSTICS, INC.
30 00855360006267 10826 10826 INTENDED USE An enzyme-linked immunosorbent assay (ELISA) for the quantitative d INTENDED USE An enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Von Willebrand Factor Activity (VWF:Act) in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY OF THE TEST Von Willebrand Factor Antigen (VWF:Ag or Factor VIII-related protein) is a plasma protein found in circulation combined by non-covalent interactions with Factor VIII (FVIII:C), a pro-coagulant protein also known as the anti-hemophilic factor. Deficiency of FVIII causes classic hemophilia while deficiency of VWF causes von Willebrand disease. Von Willebrand Disease is characterized by a deficiency or defect of VWF. Greater than 70% of Von Willebrand disease patients have a type 1 deficiency while approximately 20% have a type II deficiency. The laboratory diagnosis of Von Willebrand disease may require both quantitative and qualitative (functional) determinations to differentiate the two predominant subtypes of the disease, type I and type II. The classification of Von Willebrand disease into subtypes is important in determining the course of clinical treatment. PRINCIPLE OF THE TEST The REAADS VWF:Act assay is a sandwich ELISA. A monoclonal capture antibody specific for the portion of VWF which binds platelets is coated to 96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells. The plates are washed to remove unbound proteins and other plasma molecules. Bound antigen is quantitated using horseradish peroxidase (HRP) conjugated anti-human VWF detection antibody. Following incubation, unbound conjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogen peroxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in O.D. units with a spectrophotometer at 450 nm. Patient VWF:Act in relative percent concentration is determined against a curve made from the reference plasma provided with the kit. Refer to Product Package Insert. REAADS von Willebrand Factor Activity Test Kit CORGENIX MEDICAL CORPORATION
31 00855360006038 034-001 034-001 INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Von WillebrandFactor Antigen (VWF: Ag) in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY THE TESTVon Willebrand Factor Antigen (VWF:Ag or Factor VIII-related protein) is a plasma protein found incirculation combined by non-covalent interactions with Factor VIII (FVIII:C), a pro-coagulant protein alsoknown as the anti-hemophilic factor. These two proteins show distinct biochemical and functionalproperties as well as different antigenic determinants; their plasma levels may vary independently ofeach other. Deficiency of FVIII causes classic hemophilia while deficiency of VWF causes VonWillebrand disease. VWF:Ag plays a very important role in hemostasis. The prevalence of Von Willebrand disease has been estimated to be 1-3% of thegeneral population. Approximately 80% of Von Willebrand disease patients have a type I deficiency.The laboratory diagnosis of Von Willebrand disease may require both quantitative and qualitative(functional) determinations.PRINCIPLE OF THE TESTREAADS VWF:Ag assay is a sandwich ELISA. A capture antibody specific for human VWF is coated to96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells, allowing any availableVWF:Ag to bind to the anti-human VWF antibody on the microwell surface. The plates are washed toremove unbound proteins and other plasma molecules. Bound VWF:Ag is quantitated using horseradishperoxidase (HRP) conjugated anti-human VWF detection antibody. Following incubation, unboundconjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogenperoxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in opticaldensity (O.D.) units with a spectrophotometer at 450nm. Patient VWF:Ag in relative percentconcentration is determined against a curve made from the reference plasma provided with the kit. Refer to product package insert. REAADS von Willebrand Factor Antigen Test Kit CORGENIX MEDICAL CORPORATION
32 00855360006021 035-001 035-001 INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Protein C Antigen in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY AND EXPLANATION OF THE TESTProtein C deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism. Patients with a congenital heterozygous deficiency may present with venous thrombosis in young adulthood, while patients with the rare homozygous deficiency present with massive thrombosis (purpura fulminans) during the neonatal period. The prevalence of Protein C deficiency in the general population has been estimated at 1 in 300. In younger patients (<40-45 years) with recurrent venous thrombosis, the frequency of Protein C deficiencies may be as high as 10 to 15%. A decreased Protein C activity in plasma may be the result of low concentrations and function (type I) or only low function (type II).PRINCIPLE OF THE TESTThe Protein C Antigen assay is a sandwich ELISA. A capture antibody specific for human Protein C is coated to 96-microwell polystyrene plates. Diluted patient plasma is incubated in the wells, allowing any available Protein C to bind to the anti-human Protein C antibody on the microwell surface. The plates are washed to remove unbound proteins and other plasma molecules. Bound Protein C is quantitated using horseradish peroxidase (HRP) conjugated anti-human Protein C detection antibody. Following incubation, unbound conjugate is removed by washing. A chromogenic substrate of tetramethylbenzidine (TMB) and hydrogen peroxide (H2O2) is added to develop a colored reaction. The intensity of the color is measured in optical density (O.D.) units with a spectrophotometer at 450nm. Protein C Antigen relative percent concentrations in patient plasma are determined against a curve prepared from the reference plasma provided with the kit.Refer to Product Package Insert. REAADS Protein C Test Kit CORGENIX MEDICAL CORPORATION
33 00855360006014 051-001 051-001 INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Free Protein S Antigen in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY AND EXPLANATION OF THE PROTEIN S TESTProtein S is a vitamin K-dependent protein synthesized in the liver, vascular endothelium, and megakaryocytes, which plays an important physiologic role in the Protein C Anticoagulant System. This anticoagulant system is one of the major regulators of hemostasis by inhibiting clot formation and by promoting fibrinolysis. Protein S functions as a cofactor for activated Protein C on the vascular membrane to facilitate the degradation of clotting factors Va and VIIIa, down-regulating clot formation. In normal plasma approximately 40% of Protein S circulates as a free molecule, while 60% is complexed with C4b, a plasma protein of the classical complement pathway. Only Free Protein S is functionally active and able to bind to activated Protein C, while the complexed form of Protein S is not.Protein S deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism. The prevalence of Protein S deficiency has been estimated to be less than 1 case per 300 in the general population. Two-thirds of patients with a congenital deficiency of Protein S (levels less than 50% of normal) may present with venous thrombosis in young adulthood. In young patients (<35 years) with a history of thrombosis, the prevalence may be as high as 15 to 18%. Acquired Protein S deficiency may be seen during pregnancy, oral contraceptive or oral anticoagulant therapy, liver disease, diabetes mellitus, postoperative complications, septicemia, and various inflammatory syndromes. A decreased Protein S activity in plasma may be the result of low concentrations or abnormal function of the Protein S molecule.Refer to Product Package Insert. REAADS Monoclonal Free Protein S Antigen CORGENIX MEDICAL CORPORATION
34 00855360006007 036-001 036-001 INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative de INTENDED USEAn enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of Total and Free Protein S Antigen in citrated human plasma. For In Vitro Diagnostic Use.SUMMARY AND EXPLANATION OF THE PROTEIN S TESTProtein S is a vitamin K-dependent protein synthesized in the liver, vascular endothelium, and megakaryocytes, which plays an important physiologic role in the Protein C Anticoagulant System. This anticoagulant system is one of the major regulators of hemostasis by inhibiting clot formation and by promoting fibrinolysis. Protein S functions as a cofactor for activated Protein C on the vascular membrane to facilitate the degradation of clotting factors Va and VIIIa, downregulating clot formation. In normal plasma approximately 40% of Protein S circulates as a free molecule, while 60% is complexed with C4b, a plasma protein of the classical complement pathway. Only Free Protein S is functionally active and able to bind to activated Protein C, while the complexed form of Protein S is not.Protein S deficiency, either congenital or acquired, may lead to serious thrombotic events such as thrombophlebitis, deep vein thrombosis, or pulmonary embolism. The prevalence of Protein S deficiency has been estimated to be less than 1 case per 300 in the general population. Two-thirds of patients with a congenital deficiency of Protein S (levels less than 50% of normal) may present with venous thrombosis in young adulthood. In young patients (<35 years) with a history of thrombosis, the prevalence may be as high as 15 to 18%.7 Acquired Protein S deficiency may be seen during pregnancy, oral contraceptive or oral anticoagulant therapy, liver disease, diabetes mellitus, postoperative complications, septicemia and various inflammatory syndromes.8 A decreased Protein S activity in plasma may be the result of low concentrations or abnormal function of the Protein S molecule.Refer to Product Package Insert. REAADS Protein S Antigen Test kit CORGENIX MEDICAL CORPORATION
35 00850201006161 ACC-45 ACC-45 ACTICLOT C KIT BIOMEDICA ADI INC.
36 00850201006154 843L 843L ACTICLOT PROTEIN S BIOMEDICA ADI INC.
37 00850201006109 101201 101201 SPECTROLYSE PAI-1 BIOMEDICA ADI INC.
38 00850201006093 885 885 IMUBIND vWF ACTIVITY ELISA BIOMEDICA ADI INC.
39 00850201006048 822 822 IMUBIND PLASMA PAI-1 ELISA BIOMEDICA ADI INC.
40 00843876000558 CCCF08 CCCF08 CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantita CRYOcheck Chromogenic Factor VIII is for clinical laboratory use in the quantitative determination of factor VIII activity in 3.2% citrated human plasma. It is intended to be used in identifying factor VIII deficiency and as an aid in the management of hemophilia A in individuals aged 2 years and older. For in vitro diagnostic use CRYOcheck Factor VIII Chromogenic PRECISION BIOLOGIC INC
41 00843876000503 CCIK08 The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction The CRYOcheck FVIII Inhibitor Kit is for clinical laboratory use in conjunction with a factor VIII activity assay to enable performance of a modified Nijmegen-Bethesda assay using 3.2% citrated human plasma. It enables the determination of a functional FVIII inhibitor titer to aid in the clinical management of congenital hemophilia A in individuals aged 2 years and older. CRYOcheck™ FVIII Inhibitor Kit PRECISION BIOLOGIC INC
42 00843876000497 CSD C & S Diluent PRECISION BIOLOGIC INC
43 00843876000428 CCS-30 CRYOcheck™ Clot S™ PRECISION BIOLOGIC INC
44 00843876000411 CCS-15 CRYOcheck™ Clot S™ PRECISION BIOLOGIC INC
45 00843876000404 CCC-30 CRYOcheck™ Clot C™ PRECISION BIOLOGIC INC
46 00843876000398 CCC-15 CRYOcheck™ Clot C™ PRECISION BIOLOGIC INC
47 00842768039522 10873458 OPGL07 For the quantitative determination of free protein S antigen in human plasma col For the quantitative determination of free protein S antigen in human plasma collected from venous blood samplesin 3.2 % sodium citrate tubes on the BCS XP System, the SYSMEX CS-2500 analyzer and the SYSMEX CS-5100 analyzer. INNOVANCE Free PS Ag SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
48 00842768038211 10714565 OUBD39 Determination of ristocetin co-factor activity of von Willebrand factor in human Determination of ristocetin co-factor activity of von Willebrand factor in human plasma through platelet agglutination BC von Willebrand Reagent SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
49 00842768011917 10446500 OUVV17 Quantative determination of protein C activity as an aid in the diagnosis of inh Quantative determination of protein C activity as an aid in the diagnosis of inherited and acquired deficiencies Berichrom® Protein C SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
50 00842768011900 10446499 OUVV15 Quantative determination of protein C activity as an aid in the diagnosis of inh Quantative determination of protein C activity as an aid in the diagnosis of inherited and acquired deficiencies Berichrom® Protein C SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH